ATE254286T1 - Zwei-inkubations mit markiertem antigen verwendenes immunoassay - Google Patents

Zwei-inkubations mit markiertem antigen verwendenes immunoassay

Info

Publication number
ATE254286T1
ATE254286T1 AT98307328T AT98307328T ATE254286T1 AT E254286 T1 ATE254286 T1 AT E254286T1 AT 98307328 T AT98307328 T AT 98307328T AT 98307328 T AT98307328 T AT 98307328T AT E254286 T1 ATE254286 T1 AT E254286T1
Authority
AT
Austria
Prior art keywords
immunoassay
incubation
labeled antigen
immobilised
labelled antigen
Prior art date
Application number
AT98307328T
Other languages
German (de)
English (en)
Inventor
Justin Mark Glover
Original Assignee
Ortho Clinical Diagnostics
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Clinical Diagnostics filed Critical Ortho Clinical Diagnostics
Application granted granted Critical
Publication of ATE254286T1 publication Critical patent/ATE254286T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • G01N33/56988—HIV or HTLV
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
AT98307328T 1997-09-11 1998-09-10 Zwei-inkubations mit markiertem antigen verwendenes immunoassay ATE254286T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9719357.7A GB9719357D0 (en) 1997-09-11 1997-09-11 Immunoassay Utilizing Two Incubations With Labelled Antigen
US09/141,887 US6121006A (en) 1997-09-11 1998-08-28 Immunoassay utilizing two incubations with labeled antigen

Publications (1)

Publication Number Publication Date
ATE254286T1 true ATE254286T1 (de) 2003-11-15

Family

ID=26312227

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98307328T ATE254286T1 (de) 1997-09-11 1998-09-10 Zwei-inkubations mit markiertem antigen verwendenes immunoassay

Country Status (10)

Country Link
US (1) US6121006A (cg-RX-API-DMAC7.html)
EP (1) EP0902286B1 (cg-RX-API-DMAC7.html)
JP (1) JPH11148936A (cg-RX-API-DMAC7.html)
AT (1) ATE254286T1 (cg-RX-API-DMAC7.html)
CA (1) CA2246896C (cg-RX-API-DMAC7.html)
DE (1) DE69819643T2 (cg-RX-API-DMAC7.html)
DK (1) DK0902286T3 (cg-RX-API-DMAC7.html)
ES (1) ES2210678T3 (cg-RX-API-DMAC7.html)
GB (1) GB9719357D0 (cg-RX-API-DMAC7.html)
PT (1) PT902286E (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458528B1 (en) 1998-05-15 2002-10-01 Idexx Laboratories, Inc. Diagnosis of feline immunodeficiency virus infection using ENV/GAG polypeptide markers
US7105311B2 (en) * 2001-05-03 2006-09-12 Immunetics, Inc. Systems and methods for detection of analytes in biological fluids
US7262019B2 (en) * 2001-05-03 2007-08-28 Immunetics, Inc. System and methods for detection of Bacillus anthracis related analytes in biological fluids
GB0128583D0 (en) * 2001-11-28 2002-01-23 Rsr Ltd Detection of autoantibodies indicative of diabetes
US7514191B2 (en) * 2006-04-26 2009-04-07 Xerox Corporation Imaging member
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
PT2691530T (pt) 2011-06-10 2018-05-10 Univ Oregon Health & Science Glicoproteínas e vectores recombinantes cmv
US20130189754A1 (en) 2011-09-12 2013-07-25 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing hiv-1 proteins by broadly neutralizing antibodies
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
KR101990958B1 (ko) * 2016-08-31 2019-06-21 휴마시스 주식회사 면역학적 측정을 이용한 hiv 1형, 2형 및 o형 동시 진단용 키트 및 이를 이용한 동시 진단방법

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4789628A (en) * 1986-06-16 1988-12-06 Vxr, Inc. Devices for carrying out ligand/anti-ligand assays, methods of using such devices and diagnostic reagents and kits incorporating such devices
DE3874741T2 (de) * 1987-06-09 1993-07-22 Cambridge Life Sciences Immunassay-verfahren.
EP0313986B1 (en) * 1987-10-30 1995-12-27 Abbott Laboratories Immunoassays using antigens produced in heterologous organisms
US5683864A (en) * 1987-11-18 1997-11-04 Chiron Corporation Combinations of hepatitis C virus (HCV) antigens for use in immunoassays for anti-HCV antibodies
DE4120412C1 (cg-RX-API-DMAC7.html) * 1991-06-20 1993-01-07 Henning Berlin Gmbh Chemie- Und Pharmawerk, 1000 Berlin, De

Also Published As

Publication number Publication date
ES2210678T3 (es) 2004-07-01
US6121006A (en) 2000-09-19
DE69819643T2 (de) 2004-12-02
EP0902286B1 (en) 2003-11-12
GB9719357D0 (en) 1997-11-12
DE69819643D1 (de) 2003-12-18
PT902286E (pt) 2004-03-31
CA2246896A1 (en) 1999-03-11
EP0902286A2 (en) 1999-03-17
EP0902286A3 (en) 2000-02-23
CA2246896C (en) 2006-04-04
DK0902286T3 (da) 2004-02-02
JPH11148936A (ja) 1999-06-02

Similar Documents

Publication Publication Date Title
CY1107537T1 (el) Ανaλυση συνδυασμoy hcv αντιγoνου/αντισωματος
ATE254286T1 (de) Zwei-inkubations mit markiertem antigen verwendenes immunoassay
NO20001273L (no) Immunanalyse for BNP
AR006016A1 (es) Metodo para determinar h.pylori en muestras fecales y un equipo (kit) para realizar dicho metodo
NO970292D0 (no) Bestemmelse av et spesifikt immunoglobulin ved anvendelse av multiple antigener
KR960018584A (ko) 특이성 결합검정용 시약
EP0375422A3 (en) Composition and methods for determining the presence of amphetamines in a sample suspected of containing amphetamine and/or methamphetamine
ATE128237T1 (de) Test für hepatitis-c.
NZ330475A (en) Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation
ATE235684T1 (de) Sensitivitätssteigerung bei der immunchemischen bestimmung eines analyten
ATE310956T1 (de) Festphasenverfahren und testsatz zur antigen- und antikörperprüfung in der blutgruppen-serologie
WO2003046140A3 (en) Immunoassay and kit for an early and simulataneous detection of biochemical markers in a patient's sample
ATE320604T1 (de) Homogene nachweisverfahren zur bestimmung von subpopulationen eines analyten
FI874280A0 (fi) Immunometriskt bestaemningsfoerfarande.
GB2008247A (en) Detecting or quantifying substances using labelling techniques
BR0314166B8 (pt) teste de hcv
ATE323286T1 (de) Verfahren zum bestimmen von autoantikörpern
DE3874741D1 (de) Immunassay-verfahren.
ATE286596T1 (de) Chemische modifikation von antikörpern und antigenen
CO5300499A1 (es) Ensayo de inmunoabsorbente ligado a enzima de inhibicion (elisa) para deteccion y cuantificacion de anticuerpos en muestras biologicas
ATE173543T1 (de) Verfahren zum nachweis einer cmv-infektion
DE69917378D1 (de) Methylorange verwendende spezifische bindungsassays
ITMI930477A1 (it) Saggio per la determinazione di un antigene/anticorpo in un campione di prova e corredo per l'attuazione del saggio
ES2029890T3 (es) Inmunoensayo.
BR9102727A (pt) Processo para a preparacao de um anticorpo monoclonal, anticorpos monoclonais, linha de celulas, processo para sua preparacao, processo para a determinacao imunologica de herbicidas de sulfonilureia, agente para determinacao imunologica, componente de copulacao e processo para a preparacao de um componente

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0902286

Country of ref document: EP